The researchers noted 6,072
tuberculosis cases among children and adolescents during 2010 to 2017; 85 and 15 percent occurred in the 50 U.S.
Drug shortage to treat
tuberculosis is a major challenge to effective healthcare in the U.S., with the shortage of drug number tripling from 2007 to 2012.
According to the Department of Health,
tuberculosis is caused by the pathogenic bacteria 'Mycobacterium
Tuberculosis', which is spread through fluids secreted from the mouth and nose of
tuberculosis patients when they cough, talk or sneeze.
In Pakistan, incidence of
tuberculosis is estimated as 181 per 100,000 populations and the rising trend of drug resistance is alarming.
Tuberculosis is a major dilemma in low and middle- income countries, accounting for second leading cause of death from an infectious disease, globally.
Taking part on Sunday at an awareness day held at the Tunis Science City, on the celebration of the World
Tuberculosis Day, Gmara stated to TAP that 78% of extrapulmonary
tuberculosis are due to an infection by bovine
tuberculosis caused by consuming non-sterilised milk and its by-products as well as infected bovine meat.
The proportion of
tuberculosis cases among children and adolescents globally varies from 6.6% to 39.2%.6-12 According to the WHO, the proportion was higher in Africa (16.0% to 39.2%), followed by the Eastern Mediterranean region (35.0%), Southeast Asia (20.0%), the Americas (6.6% to 17.3%), and the Western Pacific region (8.5%).
There is a low prevalence of MTB infection (pulmonary
tuberculosis) in patients with chronic kidney disease in our setup.
In March, while commemorating the World
Tuberculosis Day, the country launched a new paediatric anti-tuberculosis formulation for the treatment of 'drug-susceptible'
tuberculosis in children.
Tuberculosis remains one of the biggest contributors to the death of most of the women and elderly people in the world but is curable and rarely deadly in infants if diagnosed and treated in time.
A new treatment for a drug-resistant strain of
tuberculosis can cure more than 90 percent of sufferers, according to a trial hailed Monday as a "game changer" in the fight against the global killer.